Page 3 - State Drug Administration News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from State drug administration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In State Drug Administration Today - Breaking & Trending Today

Ocumension OT-401 (Product name: YUTIO), a treatment for chronic non-infectious uveitis officially approved for marketing by the National Medical Products Administration

BEIJING, June 23, 2022 /PRNewswire/ Ocumension Therapeutics 1477.HKannounced that the New Drug Application (NDA) for the core product in its pipeline, OT-401 (Sterile non-bioerodible intravitreal implant, Product name: YUTIO), was officially approved by the National Pharmaceutical Administration (NMPA) for the treatment of chronic non-infectious uveitis involving the posterior segment of the eye (chronic NIU-PS). This is the first new drug in Ocumension's pipeline to be approved for marketing and is currently the potential best-in-class therapy for the treatment of this indication in China. Ocumension is a Chinese ophthalmic pharmaceutical platform company dedicated to identifying, developing and commercialising first-in-class or best-in-class ophthalmic therapies. To date, Ocumension has 23 drug assets in the immediate and posterior segments of the eye and has established a complete ophthalmic drug pipeline, of which seven products are in Phase III clinical trials and its core pr ....

Chen Wei , Liu Mimi , Sun Xin , Wenzhou Medical University Optometry Hospital , Group Hainan Campus , Drug Administration , Scientist Of The National , Key Laboratory Of Real World Data Research , Boao Lecheng International Medical Tourism Advance Zone , National Pharmaceutical Administration , Vision Hospital Of Wenzhou Medical University , Hainan Boao International Eye , Wen Medical University , Ocumension Therapeutics , New Drug Application , Boao Lecheng Advance Hospital , International Eye , Vision Eye Hospital , Professor Qu Jia , Vision Hospital , Wenzhou Medical University , Zhejiang Provincial Eye Hospital , Boao Lecheng Super , Johnson Catalys Femtosecond Laser System , Drainage Tube , State Drug Administration ,

New indications for dual-targeted combination therapy approved for lung cancer patients usher in a new choice

China News Service, Guangzhou, March 25th (Cai Minjie and Zuo Jiaolei) Lung cancer is one of the most common and most dangerous types of cancer in the world. In recent years, targeted therapy has opened a new chapter in the precise treatment of lung cancer. Dabrafenib combined with trametinib for the treatment of BRAF-mutated lung cancer was recently approved in China. Professor Zhang Li, direct ....

Zhang Li , Cai Minjie , Drug Administration , China News Service , Zuo Jiaolei , Sun Yat Sen University Cancer Center , State Drug Administration ,